← All companies

GHRS

GH Research PLC

GHRS Nasdaq Pharmaceutical Preparations EDGAR ↗

$28.19

-0.19 -0.67%

Key statistics

from XBRL data in SEC filings

Market cap

$1.75B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$11.32 – $31.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jun 26, 2026 6-K Jun 4, 2026 6-K May 21, 2026 6-K May 14, 2026 6-K May 14, 2026 6-K May 13, 2026 6-K May 13, 2026 6-K Apr 30, 2026 6-K Mar 25, 2026 6-K Mar 16, 2026 20-F Mar 5, 2026 6-K Mar 5, 2026 6-K Jan 22, 2026 6-K Jan 15, 2026 6-K Jan 13, 2026 6-K Jan 8, 2026 6-K Jan 5, 2026 6-K Jan 2, 2026 6-K Nov 24, 2025 6-K Nov 7, 2025 6-K Nov 6, 2025 6-K Oct 17, 2025 6-K Oct 14, 2025 6-K Oct 10, 2025 6-K Oct 9, 2025 6-K Sep 12, 2025 6-K Sep 9, 2025 6-K Aug 29, 2025 6-K Aug 7, 2025 6-K Aug 1, 2025 20-F/A Jul 29, 2025 6-K Jul 23, 2025 6-K Jun 20, 2025 6-K Jun 18, 2025 6-K Jun 13, 2025 6-K May 27, 2025 6-K May 21, 2025 6-K May 15, 2025 6-K May 8, 2025 20-F Feb 27, 2025